<DOC>
	<DOCNO>NCT00152282</DOCNO>
	<brief_summary>The objective study determine safety effectiveness 3 asoprisnil dos administer postmenopausal woman Premarin® 0.625 mg .</brief_summary>
	<brief_title>A Study Evaluate Safety Effectiveness Asoprisnil Estrogen Administration Postmenopausal Women</brief_title>
	<detailed_description>The objective study determine safety effectiveness asoprisnil 5 , 10 , 25 mg , compare placebo , administer postmenopausal woman , Premarin® 0.625 mg , 12 week . Pharmacodynamic effect assess include bleed pattern , endometrial biopsy result , endometrial thickness . Safety assessment include clinical laboratory result , physical examination vital sign , pelvic breast examination , ultrasound result , adverse event</detailed_description>
	<mesh_term>Amenorrhea</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<mesh_term>Estrogens , Conjugated ( USP )</mesh_term>
	<criteria>Postmenopausal woman intact uterus Body mass index ( BMI ) 18.0 33.0 Good general health Endometrial thickness ≤ 4 mm TVU No history suspect endometrial hyperplasia Negative urine pregnancy test Pap smear last 6 month evidence malignancy premalignant change Mammogram without suspicion malignancy within last 6 month Endometrial biopsy evidence pathologic change within last 6 month Any abnormal lab result studydoctor considers significant History severe reaction hormone therapy Receiving hormone therapy Currently use phytoestrogenic compound , red clover , black cohosh ( Promensil Remifemin ) , dong quai , ginseng soy isoflavones History know suspect cancer basal cell carcinoma Stenosis cervix History reproductive endocrine disorder Washout requirement hormonal therapy meet Ovarian mass Submucus symptomatic fibroid would confound efficacy</criteria>
	<gender>Female</gender>
	<minimum_age>48 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>Postmenopausal</keyword>
	<keyword>Amenorrhea</keyword>
	<keyword>Hormone replacement therapy</keyword>
	<keyword>HRT</keyword>
	<keyword>asoprisnil</keyword>
</DOC>